Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02742740 · ClinicalTrials.gov registry record · NA
Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02742740 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT02742740, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The Study Buddy ECA acts as an advisor to patients on chemotherapy regimens, promoting protocol adherence and retention, providing anticipatory guidance and answering questions, serving as a conduit to capture information about complaints or adverse events, providing a venue for communicating about updates. The Study Buddy will use the web-based ECA infrastructure developed for use on another project. We will use web browsers on tablets provided to study participants to access the Study Buddy, providing anywhere, anytime access to its functions. Usability metrics will include session time, satisfaction, and error rates.
Interventions
- BEHAVIORAL Chemo Buddy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02742740
The ClinicalTrials.gov registry entry for NCT02742740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chemo Buddy is the first listed.
NCT02742740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02742740 about?
NCT02742740 is a clinical study titled "Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials". The Study Buddy ECA acts as an advisor to patients on chemotherapy regimens, promoting protocol adherence and retention, providing anticipatory guidance and answering questions, serving as a conduit to capture information about complaints or adverse events, providing a venue for communicating about ...
What is the current status of trial NCT02742740?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-09-01. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT02742740?
The interventions under investigation include: Chemo Buddy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02742740?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.